P Glitz 15 Mg
- Manufacturer : Cipla Ltd
- Equivalent Brands : Actos
- Generic Brands : Pioglitazone
P Glitz 15mg Tablet is an effective medicine to control blood sugar levels in type II Diabetes Mellitus patients. It is to be used along with controlled diet and regular exercise. This medicine may be used in combination with other medicines for effective control.
P Glitz Tablet is used for Lower blood glucose in adults with type 2 diabetes mellitus and other conditions. P Glitz Tablet may also be used for purposes not listed in this medication guide.
P Glitz Tablet contains Pioglitazone as an active ingredient. P Glitz Tablet works by helping the body make better use of insulin by decreasing the glucose output. Cipla manufactures P Glitz Tablet.
P Glitz 15mg Tablet is an anti-diabetic medication. It works by increasing the body's sensitivity to insulin, a natural substance that helps control blood sugar levels.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. P Glitz 15mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
If you use other drugs or over the counter products at the same time, the effects of P Glitz Tablet may change. This may increase your risk for side-effects or cause your drug not to work properly. Tell your doctor about all the drugs, vitamins, and herbal supplements you are using, so that you doctor can help you prevent or manage drug interactions. P Glitz Tablet may interact with the following drugs and products:
The following is a list of possible side-effects that may occur from all constituting ingredients of P Glitz Tablet. This is not a comprehensive list. These side-effects are possible, but do not always occur. Some of the side-effects may be rare but serious. Consult your doctor if you observe any of the following side-effects, especially if they do not go away.
Pregnancy - This medicine is not recommended for use by women who are pregnant or are planning a pregnancy in the near future. Use of insulin is most preferred during early and mid-stages of pregnancy.
Breast-feeding - This medicine is not recommended for use in women who are breastfeeding. The risk of adverse effect is very high in infants and hence the potential benefits and risks should be considered before using this medicine.
Type I diabetes mellitus - This medicine is not recommended for use in patients suffering from type 1 diabetes mellitus since it is not effective in treating this condition.
Heart Failure - This medicine should be used with caution in patients having a mild heart failure. Use of this medication is not recommended if the condition is moderate to severe.
Impaired liver function - This medicine should be used with caution in patients with an impaired liver function due to an increase in the risk of worsening of the patient's condition. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Edema - This medicine should be used with caution in patients with edema due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Ovulation problems - This medicine should be used with caution in premenopausal patients due to the increase in chances of ovulation. Adequate contraceptive measures are recommended for such patients to avoid an unplanned pregnancy.
Bone fractures - This medicine may increase the risk of fractures in some patients. This risk is especially higher in female patients. Close monitoring of bone health is recommended during treatment with this medicine. Replacement with a suitable alternative may be required based on the clinical condition.
Bladder cancer - Use of this medicine has been associated with an increased risk of bladder cancer. It may also worsen the condition of patients suffering from bladder cancer.
Pediatric use - This medicine is not recommended for use in patients less than 18 years of age.
Other anti-diabetic medicines - Report the use of any other anti-diabetic medication, especially insulin to the doctor before beginning treatment with this medicine. Appropriate dose adjustments and close monitoring of blood sugar levels may be required based on the clinical condition of the patient.
P glitz helps to control blood sugar level and avoids long-term complications.
You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with P glitz.
Full effect may be visible after several weeks of starting P glitz.
Weight gain, headache, and swelling due to fluid build-up may occur.
Notify your doctor if you experience shortness of breath, heart problems, or any abnormal swelling.
May not be suitable for patients with a history of heart failure or bladder cancer.
Missed Dose : Take the missed dose as soon as you remember. However, if you have finished eating, skip the missed dose and continue with the next scheduled dose. Do not take extra medicine to make up for the missed dose.
Overdose : Seek emergency medical treatment or contact the doctor in case of an overdose. Please consult your physician or pharmacist or product package for more information.
P Glitz 15mg Tablet is used in the treatment of type 2 diabetes. It is used in addition to diet and exercise to improve blood sugar control in adults with type 2 diabetes.